Literature DB >> 12238835

An ovine model of postinfarction dilated cardiomyopathy.

Sina L Moainie1, Joseph H Gorman, T Sloane Guy, Frank W Bowen, Benjamin M Jackson, Theodore Plappert, Navneet Narula, Martin G St John-Sutton, Jagat Narula, L Henry Edmunds, Robert C Gorman.   

Abstract

BACKGROUND: Coronary arterial disease is the major cause of congestive heart failure, but suitable animal models of postinfarction, dilated cardiomyopathy do not exist. This article describes an ovine model that develops after an anterobasal infarction.
METHODS: The distribution of ovine myocardium supplied by the first two diagonal branches of the left homonymous artery were determined in 20 slaughterhouse hearts and eight live sheep using methylene blue and tetrazolium injections, respectively. Seven additional animals had the infarction and underwent serial hemodynamic, microsphere and echocardiographic studies more than 8 weeks and histologic studies at the eighth week. Infarcts represented 24.6% +/- 4.7% and 23.9% +/- 2.2% of the left ventricular mass in slaughterhouse and live hearts, respectively.
RESULTS: During remodeling, left ventricular end-systolic and end-diastolic volumes increased 115% and 73%, respectively, ejection fraction decreased from 41.2% +/- 6.7% to 29.1% +/- 5.7%, systolic wall thickening remote from the infarct decreased by 68%, sphericity index increased from 0.465 +/- 0.088 to 0.524 +/- 0.038, and left ventricular end-diastolic pressure increased from 1.7 +/- 1.0 to 8.2 +/- 3.5 mm Hg. Serial microsphere measurements documented normal blood flow (1.34 mL/g per minute) to all uninfarcted myocardium and 22% of normal to the infarct. Viable myocardium showed mild interstitial fibrosis.
CONCLUSIONS: This ovine model meets all criteria for postinfarction, dilated cardiomyopathy and has the advantages of controlling for variations in coronary arterial anatomy, collateral vascularity, and differences in the numbers, location, and severity of atherosclerotic lesions that confound human studies of the pathogenesis of this disease. This simple model contains only infarcted and fully perfused, hypocontractile myocardium produced by a moderate-sized, regional infarction.

Entities:  

Mesh:

Year:  2002        PMID: 12238835     DOI: 10.1016/s0003-4975(02)03827-4

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  20 in total

1.  Reference values for echocardiographic parameters and indexes of left ventricular function in healthy, young adult sheep used in translational research: comparison with standardized values in humans.

Authors:  Paola Locatelli; Fernanda D Olea; Andrea De Lorenzi; Fabián Salmo; Gustavo L Vera Janavel; Anna P Hnatiuk; Eduardo Guevara; Alberto J Crottogini
Journal:  Int J Clin Exp Med       Date:  2011-10-22

Review 2.  Model-specific selection of molecular targets for heart failure gene therapy.

Authors:  Michael G Katz; Anthony S Fargnoli; Catherine E Tomasulo; Louella A Pritchette; Charles R Bridges
Journal:  J Gene Med       Date:  2011-10       Impact factor: 4.565

3.  Inflammatory Responses with Left Ventricular Compromise after Induction of Myocardial Infarcts in Sheep (Ovis aries).

Authors:  Hylton P Gordon; Michael G Katz; Shahood Fazal; Virginia L Gillespie; Anthony S Fargnoli; Sarah M Gubara; Sophia J Madjarova; Jonathan A Cohen
Journal:  Comp Med       Date:  2021-06-03       Impact factor: 0.982

4.  An Imaging Protocol to Discriminate Specialized Conduction Tissue During Congenital Heart Surgery.

Authors:  Abhijit Mondal; John Lackey; Mossab Saeed; Fei-Yi Wu; Jordan K Johnson; Chao Huang; Frank B Sachse; Robert Hitchcock; Aditya K Kaza
Journal:  Semin Thorac Cardiovasc Surg       Date:  2019-02-06

5.  Elimination of ischemic mitral regurgitation does not alter long-term left ventricular remodeling in the ovine model.

Authors:  Kanji Matsuzaki; Masato Morita; Hirotsugu Hamamoto; Mio Noma; J Daniel Robb; Matthew J Gillespie; Joseph H Gorman; Robert C Gorman
Journal:  Ann Thorac Surg       Date:  2010-09       Impact factor: 4.330

6.  A novel, innovative ovine model of chronic ischemic cardiomyopathy induced by multiple coronary ligations.

Authors:  Jan D Schmitto; Suyog A Mokashi; Lawrence S Lee; Rita Laurence; Hanna Schotola; Otavio Coelho-Filho; Taufiek K Rajab; Raymond Kwong; R Morton Bolman; Michael Quintel; Lawrence H Cohn; Frederick Y Chen
Journal:  Artif Organs       Date:  2010-11       Impact factor: 3.094

7.  Allogeneic mesenchymal precursor cell therapy to limit remodeling after myocardial infarction: the effect of cell dosage.

Authors:  Hirotsugu Hamamoto; Joseph H Gorman; Liam P Ryan; Robin Hinmon; Timothy P Martens; Michael D Schuster; Theodore Plappert; Matti Kiupel; Martin G St John-Sutton; Silviu Itescu; Robert C Gorman
Journal:  Ann Thorac Surg       Date:  2009-03       Impact factor: 4.330

8.  Mesenchymal cell transplantation and myocardial remodeling after myocardial infarction.

Authors:  Jennifer A Dixon; Robert C Gorman; Robert E Stroud; Shenikqua Bouges; Hamamoto Hirotsugu; Joseph H Gorman; Timothy P Martens; Silviu Itescu; Michael D Schuster; Theodore Plappert; Martin G St John-Sutton; Francis G Spinale
Journal:  Circulation       Date:  2009-09-15       Impact factor: 29.690

9.  Application of polymer-mesh device to remodel left ventricular-mitral valve apparatus in ischemic mitral regurgitation.

Authors:  Akihisa Kataoka; Xin Zeng; J Luis Guerrero; Adam Kozak; Gavin Braithwaite; Robert A Levine; Gus J Vlahakes; Judy Hung
Journal:  J Thorac Cardiovasc Surg       Date:  2017-11-14       Impact factor: 5.209

10.  Benefits of standardizing the treatment of arrhythmias in the sheep (Ovis aries) model of chronic heart failure after myocardial infarction.

Authors:  Adrienne Dardenne; Carlos Fernandez; Alyssa Wagner; Krzysztof Milewski; Diane R Ordanes; Patricia A Mount; Yanping Cheng; Geng-Hua Yi; Gerard B Conditt; Armando Tellez; Greg L Kaluza; Juan F Granada; William P Feeney
Journal:  J Am Assoc Lab Anim Sci       Date:  2013       Impact factor: 1.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.